CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Open-market sale Director sold 4,000 shares at $76.09 ($304,360)
- 4 Open-market sale Director sold 4,000 shares at $76.08 ($304,320)
- 4 Grant or award Senior Vice President acquired 50,000 shares (grant or award)
- 4 Open-market sale Director sold 3,750 shares at $76.08 ($285,300)
- 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
- 4 Gift Chief Executive Officer gave 1,126 shares (gift)
- 4 Gift Director gave 870 shares (gift)
- 4 Option exercise Chief Executive Officer acquired 40,510 shares (option exercise)
- 4 Open-market sale Director sold 9,575 shares at an average $79.32 ($759,443)
- 4 Open-market sale Director sold 3,000 shares at an average $71.26 ($213,780)
- 4 Open-market sale Chief Executive Officer sold 55,000 shares at an average $68.73 ($3,780,347)
- 4 Open-market sale Chief Scientific Officer sold 31,250 shares at an average $69.06 ($2,158,125)
- 4 Open-market sale Chief Medical Officer sold 19,500 shares at $69.39 ($1,353,105)
- 4 Open-market sale Chief Financial Officer sold 43,505 shares at an average $69.37 ($3,018,071)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at an average $50.47 ($50,465)
Page 9 of 25 · 497 filings